Abstract
Randomised clinical trials find no protection against development of ischaemic heart disease by use of Hormone Therapy (HT) after the age of 50 years. Observational studies suggest that early menopause is a risk factor for ischaemic heart disease. Yet, a clinical very relevant question is whether HT reduces this risk associated with early menopause.
Original language | English |
---|---|
Journal | Maturitas |
Volume | 53 |
Issue number | 2 |
Pages (from-to) | 226-33 |
Number of pages | 8 |
ISSN | 0378-5122 |
DOIs | |
Publication status | Published - 20 Jan 2006 |
Keywords
- Adult
- Cohort Studies
- Denmark
- Female
- Hormone Replacement Therapy
- Humans
- Life Style
- Menopause, Premature
- Middle Aged
- Myocardial Ischemia
- Ovariectomy
- Proportional Hazards Models
- Prospective Studies
- Questionnaires
- Randomized Controlled Trials as Topic
- Risk Factors